Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012768675
Wed, 08.06.2022
IGEA Pharma N.V.
IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND THE COMPLETION OF ITS SWISS CBD EXTRACTION FACILITY.
Hoofddorp, the Netherlands, 8th June 2022. Today IGEA Pharma N.V. (SIX: IGPH) has signed a preliminary agreement with LMH Spa for a Euro 6.000.000 commitment to fund the [ … ]
Mon, 02.05.2022
IGEA Pharma N.V.
IGEA to get SIX approval to delay the 2021 annual report disclosure
Hoofddorp, the Netherlands, 2 May 2022. IGEA Pharma N.V. (SIX: IGPH) today announced the grant of a temporary exemption from its disclosure obligations with respect to the 2021 annual report.
As anticipated on 29 April 2022, further to the issuance of the new shares related to th [ … ]
Thu, 25.11.2021
IGEA Pharma N.V.
GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05
Hoofddorp, the Netherlands, 25 November 2021. IGEA Pharma N.V. (SIX: IGPH) receives an analyst vote. On Monday 22nd the research house GBC AG (www.gbc-ag.de/) publishes its first coverage equity research on the Company and from now on, GBC analysts [ … ]
Mon, 22.11.2021
IGEA Pharma N.V.
Reverse IPO of Blue Sky Natural Resources in IGEA Pharma. Realignment to
CBD extraction. Aggressive growth expected with strong scaling effects.
Blue Sky Natural Resources Ltd. (Blue Sky) was contributed to IGEA Pharma
N.V. (IGEA Pharma) on 27 September 2021 via a capital increase in kind. The
business model is now to change fundamentally. The w [ … ]
Mon, 04.10.2021
IGEA Pharma N.V.
GBC AG TO START EQUITY COVERAGE OF IGEA PHARMA
Hoofddorp, the Netherlands, 04October 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that GBCAG (www.gbc-ag.de/) will begin a full-coverage equity research on the Company.
Following the successful closing of the business combination ("Combination") with Blue Sky Natural Resources LTD ("BSNR"), an [ … ]
Thu, 30.09.2021
IGEA Pharma N.V.
IGEA DISCLOSES ITS HALF-2021 FINANCIALS
Hoofddorp, the Netherlands, 30September 2021. IGEA Pharma N.V. (SIX: IGPH) todayannounced the disclosure of its half-2021 financials.
Highlights
The Group did not generate revenue during the first six months of 2021 (previous period: revenue of TUSD 46.8);Cost of sales were TUSD 107.9 (previous period: TUSD [ … ]
Mon, 27.09.2021
IGEA Pharma N.V.
IGEA HAS BEEN GRANTED THE LISTING OF THE NEW SHARES FROM SIX EXCHANGE REGULATION.
Hoofddorp, the Netherlands, 27September 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that SIX Exchange Regulation AG ("SIX") has granted the listing of 307'700'514 new registered shares with a nominal value of EUR 0.01 each out of authorized capital of IGEA Pha [ … ]
Mon, 02.08.2021
IGEA Pharma N.V.
IGEA PHARMA TO BOOST REVENUES ENTERING THE GROWING CANNABIS MARKET
Hoofddorp, the Netherlands, 2 August 2021. IGEA Pharma N.V. (SIX: IGPH) today announced revenue expectations over the next three years of CHF264 million globally, with an expected EBITDA margin in excess of 50% and expected net results of CHF126 million of the joint venture the Gro [ … ]
Mon, 26.07.2021
IGEA Pharma N.V.
IGEA ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD NOW UNCONDITIONAL AS TO ACCEPTANCES.
Hoofddorp, the Netherlands, 26 July 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that the all equity offer (the "Offer") to Blue Sky Natural Resources Ltd is now unconditional as to acceptances.
Following the Offer on the 30.06.2021, after a period [ … ]
Sat, 10.07.2021
IGEA Pharma N.V.
IGEA ANNOUNCES ANNUAL GENERAL MEETING RESOLUTIONS
Hoofddorp, the Netherlands, 9 July 2021. IGEA Pharma N.V. (SIX: IGPH) today announced that its shareholders followed the recommendations of the company. The minutes of the general meeting is available athttps://www.igeapharma.nl/category/information-for-shareholders/
***
About IGEA
IGEA Pharma N [ … ]